| #399 |
Robert Müller |
Genentech |
5 |
| #399 |
Henryk Zulewski |
The General Hospital |
5 |
| #399 |
Michael Lambrigger |
Endress+Hauser Flowtec Ag |
5 |
| #399 |
Willy Maurer |
Ciba-Geigy |
5 |
| #399 |
Jurg Speich |
Ciba-Geigy |
5 |
| #399 |
Robert Karl Muller |
Roche Vitamins |
5 |
| #399 |
Georg Schoefberger |
Clariant Finance (Bvi) Limited |
5 |
| #399 |
Anne-Hortense Schmitt-Hoffmann |
Glaxo Group Limited |
5 |
| #399 |
Christian Leist |
Novartis Ag |
5 |
| #399 |
John Geurts |
Dsm Ip Assets B.V. |
5 |
| #399 |
Rene Beerli |
Novartis Ag |
5 |
| #399 |
Donald F. Gerson |
Apotex |
5 |
| #399 |
Jochen Nicolai |
Cochlear Limited |
5 |
| #399 |
Bernhard Fasching |
Endogena Therapeutics |
5 |
| #399 |
Lukas Schneider |
Roche Molecular Systems |
5 |
| #399 |
Walter Scherrer |
Novartis Ag |
5 |
| #399 |
Marianne Rouge |
Hoffmann-La Roche |
5 |
| #399 |
Giuseppe Lapadula |
Merck |
5 |
| #399 |
Fiona Murphy Kessabi |
Syngenta Corp Protection |
5 |
| #399 |
Ernst Kupfer |
Hoffmann-La Roche |
5 |
| #399 |
Hugues Matile |
Hoffmann-La Roche |
5 |
| #399 |
Romain Wolf |
Novartis Ag |
5 |
| #399 |
Hans Juerg Kirner |
Basf Se |
5 |
| #399 |
Jascha-Nikolai Rybak |
Philogen S.P.A. |
5 |
| #399 |
Daniel Heizler |
Basf Se |
5 |
| #399 |
Francois Diederich |
Hoffmann-La Roche |
5 |
| #399 |
Bindhumadhavan Gururajan |
Novartis Ag |
5 |
| #399 |
Francesco Sinigaglia |
Hoffmann-La Roche |
5 |
| #399 |
Judith A. Hay |
Pepperdata |
5 |
| #399 |
Søren Skov |
Xcyte Therapies |
5 |
| #399 |
Werner Baschong |
Ciba Specialty Chemicals |
5 |
| #399 |
Samuel Hintermann |
Novartis Ag |
5 |
| #399 |
Juraj Velcicky |
Novartis Ag |
5 |
| #399 |
Yaakov Benenson |
Eth Zurich |
5 |
| #399 |
Rita Locher |
Hoffmann-La Roche |
5 |
| #399 |
Cinzia Tartarini |
Basf Se |
5 |
| #399 |
Andrea Montali |
Depuy Synthes Products |
5 |
| #399 |
Gemma Veitch |
Basf Se |
5 |
| #489 |
Christoph Luethy |
Syngenta Crop Protection Ag |
4 |
| #489 |
Vladimir Cmiljanovic |
University Of Basel |
4 |
| #489 |
Alfred Puck |
Ciba-Geigy |
4 |
| #489 |
Christophe Royer |
Novartis Ag |
4 |
| #489 |
Marcel Blommers |
Novartis Ag |
4 |
| #489 |
Marc Hollmach |
Endress+Hauser Flowtec Ag |
4 |
| #489 |
Vaclav Mandak |
Ciba-Geigy |
4 |
| #489 |
Saverio Fornelli |
Sandoz Ag |
4 |
| #489 |
Christophe Malan |
Chirotech Technology Limited |
4 |
| #489 |
Rolf Kuratli |
Ciba Specialty Chemicals |
4 |
| #489 |
Frank Bamberg |
Genentech |
4 |
| #489 |
Armin Schaffner |
Ciba-Geigy |
4 |